Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 10 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: E9AZZ6
Term | Name | Level | Count |
---|---|---|---|
GO:0005096 | GTPase activator activity | 4 | 7 |
GO:0008047 | enzyme activator activity | 3 | 7 |
GO:0030234 | enzyme regulator activity | 2 | 7 |
GO:0030695 | GTPase regulator activity | 4 | 7 |
GO:0060589 | nucleoside-triphosphatase regulator activity | 3 | 7 |
GO:0098772 | molecular function regulator activity | 1 | 7 |
GO:0140677 | molecular function activator activity | 2 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 242 | 246 | PF00656 | 0.547 |
CLV_C14_Caspase3-7 | 281 | 285 | PF00656 | 0.523 |
CLV_NRD_NRD_1 | 64 | 66 | PF00675 | 0.508 |
DEG_SPOP_SBC_1 | 129 | 133 | PF00917 | 0.543 |
DEG_SPOP_SBC_1 | 211 | 215 | PF00917 | 0.686 |
DEG_SPOP_SBC_1 | 46 | 50 | PF00917 | 0.233 |
DOC_CKS1_1 | 81 | 86 | PF01111 | 0.678 |
DOC_USP7_MATH_1 | 129 | 133 | PF00917 | 0.569 |
DOC_USP7_MATH_1 | 189 | 193 | PF00917 | 0.653 |
DOC_USP7_MATH_1 | 212 | 216 | PF00917 | 0.632 |
DOC_USP7_MATH_1 | 258 | 262 | PF00917 | 0.570 |
DOC_USP7_UBL2_3 | 62 | 66 | PF12436 | 0.410 |
DOC_WW_Pin1_4 | 80 | 85 | PF00397 | 0.635 |
DOC_WW_Pin1_4 | 96 | 101 | PF00397 | 0.800 |
LIG_14-3-3_CanoR_1 | 116 | 125 | PF00244 | 0.486 |
LIG_BRCT_BRCA1_1 | 201 | 205 | PF00533 | 0.632 |
LIG_FHA_1 | 211 | 217 | PF00498 | 0.510 |
LIG_FHA_1 | 269 | 275 | PF00498 | 0.671 |
LIG_FHA_1 | 50 | 56 | PF00498 | 0.470 |
LIG_FHA_1 | 91 | 97 | PF00498 | 0.810 |
LIG_FHA_2 | 240 | 246 | PF00498 | 0.752 |
LIG_FHA_2 | 279 | 285 | PF00498 | 0.561 |
LIG_FHA_2 | 81 | 87 | PF00498 | 0.594 |
LIG_LIR_Apic_2 | 123 | 129 | PF02991 | 0.717 |
LIG_LIR_Nem_3 | 155 | 160 | PF02991 | 0.697 |
LIG_Pex14_2 | 205 | 209 | PF04695 | 0.628 |
LIG_PTB_Apo_2 | 67 | 74 | PF02174 | 0.346 |
LIG_SH2_GRB2like | 68 | 71 | PF00017 | 0.261 |
LIG_SH2_NCK_1 | 169 | 173 | PF00017 | 0.727 |
LIG_SH2_STAP1 | 36 | 40 | PF00017 | 0.410 |
LIG_SH2_STAP1 | 63 | 67 | PF00017 | 0.484 |
LIG_SH3_3 | 188 | 194 | PF00018 | 0.559 |
LIG_SH3_3 | 213 | 219 | PF00018 | 0.770 |
LIG_SH3_3 | 225 | 231 | PF00018 | 0.667 |
LIG_SH3_3 | 234 | 240 | PF00018 | 0.604 |
LIG_WW_3 | 104 | 108 | PF00397 | 0.556 |
MOD_CK1_1 | 132 | 138 | PF00069 | 0.719 |
MOD_CK1_1 | 178 | 184 | PF00069 | 0.792 |
MOD_CK1_1 | 283 | 289 | PF00069 | 0.678 |
MOD_CK1_1 | 90 | 96 | PF00069 | 0.689 |
MOD_CK1_1 | 99 | 105 | PF00069 | 0.644 |
MOD_CK2_1 | 258 | 264 | PF00069 | 0.618 |
MOD_CK2_1 | 45 | 51 | PF00069 | 0.315 |
MOD_CK2_1 | 58 | 64 | PF00069 | 0.508 |
MOD_GlcNHglycan | 118 | 121 | PF01048 | 0.595 |
MOD_GlcNHglycan | 196 | 199 | PF01048 | 0.787 |
MOD_GlcNHglycan | 201 | 204 | PF01048 | 0.676 |
MOD_GlcNHglycan | 225 | 228 | PF01048 | 0.698 |
MOD_GlcNHglycan | 256 | 259 | PF01048 | 0.604 |
MOD_GlcNHglycan | 90 | 93 | PF01048 | 0.617 |
MOD_GSK3_1 | 128 | 135 | PF00069 | 0.770 |
MOD_GSK3_1 | 144 | 151 | PF00069 | 0.545 |
MOD_GSK3_1 | 155 | 162 | PF00069 | 0.596 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.729 |
MOD_GSK3_1 | 254 | 261 | PF00069 | 0.592 |
MOD_GSK3_1 | 264 | 271 | PF00069 | 0.448 |
MOD_GSK3_1 | 278 | 285 | PF00069 | 0.581 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.371 |
MOD_GSK3_1 | 40 | 47 | PF00069 | 0.427 |
MOD_GSK3_1 | 86 | 93 | PF00069 | 0.667 |
MOD_GSK3_1 | 95 | 102 | PF00069 | 0.607 |
MOD_N-GLC_1 | 199 | 204 | PF02516 | 0.648 |
MOD_N-GLC_1 | 254 | 259 | PF02516 | 0.687 |
MOD_NEK2_1 | 143 | 148 | PF00069 | 0.701 |
MOD_NEK2_1 | 156 | 161 | PF00069 | 0.472 |
MOD_NEK2_1 | 179 | 184 | PF00069 | 0.529 |
MOD_NEK2_1 | 268 | 273 | PF00069 | 0.614 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.508 |
MOD_PIKK_1 | 136 | 142 | PF00454 | 0.816 |
MOD_PIKK_1 | 204 | 210 | PF00454 | 0.654 |
MOD_PK_1 | 7 | 13 | PF00069 | 0.433 |
MOD_Plk_4 | 16 | 22 | PF00069 | 0.350 |
MOD_Plk_4 | 212 | 218 | PF00069 | 0.777 |
MOD_Plk_4 | 264 | 270 | PF00069 | 0.612 |
MOD_ProDKin_1 | 80 | 86 | PF00069 | 0.648 |
MOD_ProDKin_1 | 96 | 102 | PF00069 | 0.800 |
MOD_SUMO_rev_2 | 61 | 67 | PF00179 | 0.508 |
TRG_DiLeu_BaLyEn_6 | 30 | 35 | PF01217 | 0.410 |
TRG_ER_diArg_1 | 30 | 33 | PF00400 | 0.411 |
TRG_Pf-PMV_PEXEL_1 | 33 | 37 | PF00026 | 0.410 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDT1 | Leptomonas seymouri | 41% | 74% |
A0A3S7X1K9 | Leishmania donovani | 80% | 100% |
A4HGN0 | Leishmania braziliensis | 58% | 100% |
A4I3Q4 | Leishmania infantum | 81% | 100% |
Q4Q889 | Leishmania major | 79% | 100% |